Print page

Email page

Lutter Briefs House Subcommittee on FDA's Anti-Counterfeiting Action Plan

PharmaManufacturing.com

Randall W. Lutter, Ph.D., FDA's Associate Commissioner for Policy and Planning, on July 11 addressed the House Committee on Government Reform's Subcommittee on Criminal Justice, Drug Policy, and Human Resources. He reported on the progress — and lack thereof — that FDA and industry have made toward the goals outlined in the Agency's "Combatting Counterfeit Drugs" report.

http://www.fda.gov/ola/2006/counterfeit0711.html